Assessment of mutations in KCNN2 and ZNF135 to patient neurological symptoms

Vijeta Raghuram, Sydney Weber, Jacob Raber, Dong Hui Chen, Thomas D. Bird, James Maylie, John P. Adelman

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Exome sequencing from a patient with neurological and developmental symptoms revealed two mutations in separate genes. One was a homozygous transition mutation that results in an in-frame, premature translational stop codon in the ZNF135 gene predicted to encode a transcriptional repressor. Another mutation was heterozygous, a single nucleotide duplication in the KCNN2 gene that encodes a Ca2+-activated K+ channel, SK2, and leads to a translational frame shift and a premature stop codon. Heterologous expression studies, brain slice recordings, and coordination tests from a transgenic mouse line carrying the SK2 mutation suggest that it does not contribute to the patient's symptoms. ZNF135 is expressed in human brain and it is likely that the homozygous mutation underlies the human phenotype.

Original languageEnglish (US)
Pages (from-to)375-379
Number of pages5
Issue number7
StatePublished - 2017


  • CRISPR-Cas system
  • SK potassium channel
  • ZNF135
  • apamin
  • ataxia
  • human exome sequencing
  • neuroscience
  • transgenic mice

ASJC Scopus subject areas

  • General Neuroscience


Dive into the research topics of 'Assessment of mutations in KCNN2 and ZNF135 to patient neurological symptoms'. Together they form a unique fingerprint.

Cite this